Management of Pleural Effusion in the Cancer Patient

ABSTRACT

The differential diagnosis of a pleural effusion is expanded in the cancer patient. A cancer patient may have a malignant pleural effusion, a pleural effusion indirectly caused by the cancer or its treatment, or a pleural effusion unrelated to the cancer. The approach to the cancer patient with a pleural effusion must take into account the impact of the pleural effusion on quality of life, type and stage of the underlying cancer, impact of biopsy procedures on cancer staging, availability of treatment of the underlying cancer, performance status, and patient preferences. Minimally invasive palliative treatment options for the management of symptomatic malignant pleural effusion, such as chronic indwelling pleural catheters, have not only changed the treatment of the effusion but also require a reassessment of what constitutes an adequate diagnostic evaluation prior to considering such treatment options. Of particular concern to the clinician is the cytologically negative exudative pleural effusion for which a cause could not be established after the initial diagnostic evaluation. The decision to proceed to more invasive diagnostic testing must be individualized and the clinician must consider the limitations of histopathological examination of tissue obtained by invasive procedures.

KEYWORDS

Paramalignant pleural effusion - malignant pleural effusion - pleural fluid analysis - pleural biopsy - thoracoscopy

REFERENCES

• 1 Sahn S A. The diagnostic value of pleural fluid analysis.  Semin Respir Crit Care Med. 1995;  16 269-278
• 2 van den Toorn L M, Schaap E, Surmont V F, Pouw E M, van der Rijt K C, van Klaveren R J. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.  Lung Cancer. 2005;  50 123-127
• 3 Putnam Jr J B, Walsh G L, Swisher S G et al.. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.  Ann Thorac Surg. 2000;  69 369-375
• 4 Pollak J S, Burdge C M, Rosenblatt M, Houston J P, Hwu W J, Murren J. Treatment of malignant pleural effusions with tunneled long-term drainage catheters.  J Vasc Interv Radiol. 2001;  12 201-208
• 5 Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.  Chest. 2006;  129 362-368
• 6 Pien G W, Gant M J, Washam C L, Sterman D H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.  Chest. 2001;  119 1641-1646
• 7 Musani A I, Haas A R, Seijo L, Wilby M, Sterman D H. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.  Respiration. 2004;  71 559-566
• 8 Saffran L, Ost D E, Fein A M, Schiff M J. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter.  Chest. 2000;  118 417-421
• 9 Sartori S, Tombesi P, Tassinari D et al.. Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions.  J Ultrasound Med. 2004;  23 1171-1176
• 10 Caglayan B, Torun E, Turan D et al.. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.  Ann Surg Oncol. 2008;  15 2594-2599
• 11 Heffner J E. Management of the patient with a malignant pleural effusion.  Semin Respir Crit Care Med. 2010;  In press
• 12 Mayo P H, Doelken P. Pleural ultrasonography.  Clin Chest Med. 2006;  27 215-227
• 13 Barnes T W, Morgenthaler T I, Olson E J, Hesley G K, Decker P A, Ryu J H. Sonographically guided thoracentesis and rate of pneumothorax.  J Clin Ultrasound. 2005;  33 442-446
• 14 Swiderek J, Morcos S, Donthireddy V et al.. Prospective study to determine the volume of pleural fluid required to diagnose malignancy.  Chest. 2010;  137 68-73
• 15 Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis.  Chest. 2006;  129 1556-1560
• 16 Feller-Kopman D. Therapeutic thoracentesis: the role of ultrasound and pleural manometry.  Curr Opin Pulm Med. 2007;  13 312-318
• 17 Huggins J T, Doelken P. Pleural manometry.  Clin Chest Med. 2006;  27 229-240
• 18 Benamore R E, Scott K, Richards C J, Entwisle J J. Image-guided pleural biopsy: diagnostic yield and complications.  Clin Radiol. 2006;  61 700-705
• 19 Agarwal P P, Seely J M, Matzinger F R et al.. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy.  Radiology. 2006;  241 589-594
• 20 Diacon A H, Schuurmans M M, Theron J, Schubert P T, Wright C A, Bolliger C T. Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists.  Respiration. 2004;  71 519-522
• 21 Noppen M. The utility of thoracoscopy in the diagnosis and management of pleural disease.  Semin Respir Crit Care Med. 2010;  In press
• 22 Agrawal V, Doelken P, Sahn S A. Pleural fluid analysis in chylous pleural effusion.  Chest. 2008;  133 1436-1441
• 23 Huggins J T, Sahn S A, Heidecker J, Ravenel J G, Doelken P. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT.  Chest. 2007;  131 206-213
• 24 Abu-Shakra M, Nicol P, Urowitz M B. Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy.  J Rheumatol. 1994;  21 934-937
• 25 Everts C S, Westcott J L, Bragg D G. Methotrexate therapy and pulmonary disease.  Radiology. 1973;  107 539-543
• 26 Walden P A, Mitchell-Weggs P F, Coppin C, Dent J, Bagshawe K D. Pleurisy and methotrexate treatment.  BMJ. 1977;  2 867
• 27 Jones S E, Moore M, Blank N, Castellino R A. Hypersensitivity to procarbazine (Matulane) manifested by fever and pleuropulmonary reaction.  Cancer. 1972;  29 498-500
• 28 Farney R J, Morris A H, Armstrong J D, Hammer S. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.  Am Rev Respir Dis. 1977;  115 135-145
• 29 Ecker M D, Jay B, Keohane M F. Procarbazine lung.  AJR Am J Roentgenol. 1978;  131 527-528
• 30 Schaap N, Raymakers R, Schattenberg A, Ottevanger J P, de Witte T. Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT.  Bone Marrow Transplant. 1996;  18 247-248
• 31 Orwoll E S, Kiessling P J, Patterson J R. Interstitial pneumonia from mitomycin.  Ann Intern Med. 1978;  89 352-355
• 32 Gunstream S R, Seidenfeld J J, Sobonya R E, McMahon L J. Mitomycin-associated lung disease.  Cancer Treat Rep. 1983;  67 301-304
• 33 Ozols R F, Hogan W M, Ostchega Y, Young R C. MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity.  Cancer Treat Rep. 1983;  67 721-722
• 34 Wohlrab J L, Liu M C, Anderson E D, Kia Noury D B, Read C A, Warren R D. Docetaxel induced pleural effusions.  [abstract] Chest. 2002;  122 S94-S95
• 35 Goldblatt M, Huggins J T, Doelken P, Gurung P, Sahn S A. Dasatinib-induced pleural effusions: a lymphatic network disorder?.  Am J Med Sci. 2009;  338 414-417